We are dreaming
a world without diseases
Doctors & Patients
Smiling Together
Save time
Save the life
We can make it happen
with MDx technology
ECCMID 2018
Seegene Integrated Symposium
April 22nd, 2018
Expansion of the All-in-One paltform, a solution for diagnosis of infectious diseases
2019-nCoV Assay (USA Only)
Simultaneous detection
and identification of 3 target genes specific for COVID-19
All in One
All MDx Assays in One Platform
Beyond the current HPV diagnosis
Clinically validated Seegene HPV assays
Universal extraction system
Unified NA extraction for all specimens
SARS-CoV-2 Assay
Detection of 4 target genes for SARS-CoV-2 using multiplex real-time PCR
2019-nCoV Assay
Simultaneous detection
and identification of 3 target genes specific for COVID-19
Flexible PCR setup solution
Increasing your laboratory efficiency with a highly flexible system
High specificity & sensitivity
Seegene's products using original technologies provide exceptional performance
Benefit of full panel assays
Full panel assays test multiple pathogens accurately in a single run without any other method
Seegene’s COVID-19 test kit, expansion of supply to 54 countries by adding Canada with the receipt of its Emergency Use Authorization
World’s major medias, focusing on Seegene’s COVID-19 diagnostic product
Holding Seegene German Symposium for Customers
Seegene Awarded Presidential Accreditation Plaque for Korea’s Best Job
Seegene introduces New STI products with superior performance
Seegene's gastrointestinal tract infection test product, evaluate to be superior to the culture method or the diagnosis using a microscope
Korean Society for Laboratory Medicine’s Fall Symposium on Laboratory Medicine in Artificial Intelligence
Seegene exported 10 Million COVID-19 Diagnostic Tests to Over 60 countries
How One Firm's Covid-19 Tests Help Control The Virus In South Korea
CNN spotlighted “How this south Korean company created coronavirus test kits in three weeks"
Seegene Highlights Clinical Automated Nucleic Acid Extraction System at ASM Microbe 2019
Seegene Establishes Brazilian Subsidiary Seegene Brazil Diagnostics LTDA to target IVD market in Latin America
Seegene launches a new anti-microbial drug resistance test kit, replacing the conventional culture method
Seegene develops world’s first multiplex MDx assays with its AI system
Seegene inks MOU with global automated instrumentation leader Hamilton Company
KSCM General Meeting
10 Jul, 2020
Chung-nam, Republic of Korea
KSP Annual Spring Meeting
16 Jul, 2020
Gyeongju, Republic of Korea
IPVC
20 Jul, 2020
Barcelona, Spain
KSGD
28 Jul, 2020
Seoul, Republic of Korea
ESCCAR&ESCR
24 Aug, 2020
Lausanne, Switzerland
IVD products
Platform
News & Media
Advantages
Technologies
Contact UsAbout Us R&D Partnership Global Network Contact Us Privacy Policy
Copyright © Seegene Inc. All rights reserved.
Information contained in this website is for a wide range of audiences and may contain product details or information not accessible or valid in your country. Please note that we do not take any responsibility for accessing information that does not comply with any legal process, regulation, registration or usage in your country.